文献速递慢性静脉疾病

冷冻保存胎盘组织伤口基质治疗慢性静脉性腿部溃疡的前瞻性研究

Prospective study of cryopreserved placental tissue wound matrix in the management of chronic venous leg ulcers.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2019-01-06

这项前瞻性单中心开放标签单臂研究纳入21例C6级慢性静脉性腿部溃疡患者,其溃疡经至少12周标准治疗(含每周多层压力治疗和局部伤口护理)未愈合。随后患者在标准治疗基础上接受人活体伤口基质(hVWM)每1–2周应用,自身对照比较。结果显示53%(16/30)溃疡完全愈合,平均治疗10.9周后溃疡面积平均减少79%,优于标准治疗。

要点

  • 对标准治疗至少12周未愈的C6级静脉性腿部溃疡,加用hVWM后53%完全愈合。
  • hVWM治疗溃疡面积平均减少速率为每日1.69%,标准治疗为每日0.73%。

核心结论

  • 冷冻保存胎盘组织(hVWM)可改善难治性慢性静脉性腿部溃疡的愈合过程,使显著比例达到完全愈合。
  • 作为辅助治疗,hVWM在难治性静脉性腿部溃疡中提供优于标准治疗的愈合率。

研究设计与样本

  • 前瞻性单中心开放标签单臂研究,纳入临床C6级静脉性腿部溃疡患者。
  • 所有患者溃疡经至少12周标准治疗(含每周多层压力治疗和局部伤口护理)未愈合。
  • 同一患者随后在标准治疗基础上接受hVWM每1–2周应用,自身对照比较。
  • 共纳入21例连续合格患者的30处静脉性腿部溃疡。

主要发现

  • 所有患者均为男性,平均年龄67岁(SD ±10.8岁)。
  • hVWM开始前静脉性溃疡平均面积为12.2 cm²(SD ±14.6 cm²;范围3.3–12.3 cm²)。
  • 双功超声证实所有患者存在浅静脉或深静脉系统反流。
  • 对标准治疗难治的静脉性腿部溃疡应用hVWM后,53%(16/30)达到完全愈合。
  • 平均治疗10.9周后,伤口表面积平均减少79%(SD ±27.3%;与标准治疗相比P < .001)。

关键数值与推荐

  • hVWM应用后溃疡面积平均减少速率为每日1.69%,标准治疗为每日0.73%(P = .01)。

临床怎么用

  • 对于经至少12周标准治疗(含多层压力治疗和局部伤口护理)未愈合的C6级静脉性腿部溃疡,可考虑在标准治疗基础上加用hVWM。
  • hVWM每1–2周应用一次,作为辅助治疗可能提高难治性静脉性腿部溃疡的愈合率。

局限性

  • 单中心、开放标签、单臂设计,自身对照,可能存在偏倚。
  • 样本量较小(21例患者、30处溃疡),所有患者均为男性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic venous leg ulcers (VLUs) affect up to 2% of the general population, resulting in a significant socioeconomic burden. Placental tissue that contains mesenchymal stem cells and active growth factors has been shown to be beneficial in healing of chronic wounds. We compared the efficacy of a human viable wound matrix (hVWM) of cryopreserved placental tissue for the treatment of refractory VLUs with standard therapy. METHODS: This prospective single-center open-label single-arm study enrolled patients with Clinical, Etiology, Anatomy, and Pathophysiology clinical class C6 VLUs. The ulcers of all enrolled patients had failed to heal after a trial of standard therapy of at least 12 weeks, which included weekly multilayer compression therapy along with local wound care. The same patients subsequently received application of hVWM (Grafix; Osiris Therapeutics, Columbia, Md) every 1 to 2 weeks in addition to standard therapy. Healing with hVWM therapy was then compared with standard therapy, with each patient serving as his own control. RESULTS: There were 30 VLUs in 21 consecutive eligible patients who were enrolled in the study. All patients were men with an average age of 67 years (standard deviation [SD], ±10.8 years), and the average area of venous ulcers before hVWM initiation was 12.2 cm2 (SD, ±14.6 cm2; range, 3.3-12.3 cm2). Duplex ultrasound confirmed superficial or deep system venous reflux in all patients. Complete ulcer healing was achieved in 53% (16/30) of VLUs refractory to standard therapy after application of hVWM. There was a mean reduction in wound surface area by 79% (SD, ±27.3%; P < .001 compared with standard therapy) after a mean treatment time of 10.9 weeks. Eighty percent of VLUs were reduced in size by half compared with 25% with standard therapy (P < .001). The mean rate of reduction in ulcer area after hVWM applications was 1.69% per day vs 0.73% per day with standard therapy (P = .01). CONCLUSIONS: Cryopreserved placental tissue (hVWM) improves healing processes to achieve complete wound closure in a significant proportion of chronic VLUs refractory to standard therapy. Adjunctive therapy with hVWM provides superior healing rates in refractory VLUs.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Farivar BS, Toursavadkohi S, Monahan TS, et al. Prospective study of cryopreserved placental tissue wound matrix in the management of chronic venous leg ulcers. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 30621916. doi:10.1016/j.jvsv.2018.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。